宫腔镜切除术与超声引导下扩宫清宫术治疗剖宫产瘢痕妊娠的随机临床试验
在意大利单中心开展的平行组、非盲随机临床试验纳入54例孕周<8周6天、胚胎心管搏动阳性且要求终止妊娠的剖宫产瘢痕妊娠妇女,1:1随机接受宫腔镜切除术或超声引导下扩宫清宫术,两组均于随机化当日及第3天肌注甲氨蝶呤50 mg/m2。宫腔镜组成功率100%(27/27),扩宫清宫组81.5%(22/27),相对危险度1.22(95%CI 1.01-1.48)。
要点
- 宫腔镜切除术治疗剖宫产瘢痕妊娠的成功率高于超声引导下扩宫清宫术。
- 扩宫清宫组5例需额外手术,包括3例子宫切除术、1例开腹子宫节段切除术和1例宫腔镜切除术。
- 两组均未报告重症监护室入住或孕产妇死亡。
核心结论
- 与超声引导下扩宫清宫术相比,宫腔镜切除术与剖宫产瘢痕妊娠治疗成功率升高相关。
研究设计与样本
- 平行组、非盲随机临床试验,在意大利单中心开展。
- 纳入孕周<8周6天、胚胎心管搏动阳性且要求终止妊娠的剖宫产瘢痕妊娠妇女,共54例入组并随机化。
- 按1:1随机分为宫腔镜切除术组(干预组)和超声引导下扩宫清宫术组(对照组)。
- 两组均于随机化当日(第1天)及第3天肌注甲氨蝶呤50 mg/m2,若第5天胎心搏动持续存在则计划给予第三剂甲氨蝶呤。
- 在末次甲氨蝶呤给药后1至5天行超声引导下扩宫清宫术或宫腔镜切除术。
主要发现
- 总体10例妇女接受第三剂甲氨蝶呤,其中宫腔镜切除术组7/27(25.9%),扩宫清宫术组3/27(11.1%)。
- 成功率宫腔镜切除术组为100%(27/27),扩宫清宫术组为81.5%(22/27),相对危险度1.22(95%CI 1.01-1.48)。
- 对照组5例需额外手术,分别为3例子宫切除术、1例开腹子宫节段切除术和1例宫腔镜切除术。
- 住院时间干预组为9.0±2.9天,对照组为10.0±3.5天,平均差-1.00天(95%CI -2.71至0.71)。
- 未报告重症监护室入住或孕产妇死亡病例。
关键数值与推荐
- 主要结局为治疗方案成功率,定义为剖宫产瘢痕妊娠完全消退前无需进一步治疗。
- 剖宫产瘢痕妊娠消退依据β-hCG下降及宫腔内无残留妊娠物评估。
- 治疗失败定义为剖宫产瘢痕妊娠完全消退前需进一步治疗。
临床怎么用
- 对于要求终止妊娠的剖宫产瘢痕妊娠妇女,宫腔镜切除术与超声引导下扩宫清宫术相比与成功率升高相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cesarean scar ectopic pregnancy is a type of ectopic pregnancy in which the fertilized egg is implanted in the muscle or fibrous tissue of the scar after a previous cesarean delivery. The condition can be catastrophic if not managed on time and can lead to significant morbidity and mortality. Several approaches have been studied for the management of cesarean scar ectopic pregnancy in women who opted for termination of pregnancy with no consensus on the best treatment modality reached so far. OBJECTIVE: This study aimed to compare the success rate of hysteroscopic resection vs ultrasound-guided dilation and evacuation for the treatment of cesarean scar ectopic pregnancy. STUDY DESIGN: This was a parallel group, nonblinded, randomized clinical trial conducted at a single center in Italy. Women with singleton gestations at <8 weeks and 6 days of gestation were included in the study. Inclusion criteria were women with a cesarean scar ectopic pregnancy with positive embryonic heart activity who opted for termination of pregnancy. Patients were randomized 1:1 to receive either hysteroscopic resection (ie, intervention group) or ultrasound-guided dilation and evacuation (ie, control group). Both groups received 50 mg/m2 of methotrexate intramuscularly at the time of randomization (day 1) and another dose at day 3. A third dose of methotrexate was planned in case of persistence of positive fetal heart activity at day 5. Participants received either ultrasound-guided dilation and evacuation or hysteroscopic resection from 1 to 5 days after the last dose of methotrexate. Hysteroscopic resection was performed under spinal anesthesia using a 15 Fr bipolar mini-resectoscope. Dilation and evacuation were performed by vacuum aspiration with a Karman cannula, followed by sharp curettage, if necessary, under ultrasound guidance. The primary outcome was the success rate of the treatment protocol, defined as no further treatment required until the complete resolution of the cesarean scar ectopic pregnancy. Resolution of the cesarean scar ectopic pregnancy was evaluated based on decline of beta-hCG and the absence of residual gestational material in the endometrial cavity. Treatment failure was defined as the necessity for further treatment required until the complete resolution of the cesarean scar ectopic pregnancy. A sample size calculation indicated that 54 participants were required to test the hypothesis RESULTS: A total of 54 women were enrolled and randomized. Number of previous cesarean deliveries ranged from 1 to 3. Overall, 10 women received a third dose of methotrexate with 7 of 27 (25.9%) participants in the hysteroscopic resection group and 3 of 27 (11.1%) in the dilation and evacuation group. The success rate was 100% (27/27) in the hysteroscopic resection group and 81.5% (22/27) in the dilation and evacuation group (relative risk, 1.22; 95% confidence interval, 1.01-1.48). Additional procedures were required in 5 cases of the control group, namely 3 hysterectomies, 1 laparotomic uterine segmental resection, and 1 hysteroscopic resection. The length of stay in the hospital was 9.0±2.9 days in the intervention group and 10.0±3.5 days in the control group (mean difference, -1.00 days; 95% confidence interval, -2.71 to 0.71). No cases of admission to intensive care unit or maternal death were reported. CONCLUSION: Hysteroscopic resection was associated with an increased success rate in the treatment of cesarean scar ectopic pregnancy when compared with ultrasound-guided dilation and evacuation.
引用
- Di Spiezio Sardo A, Zizolfi B, Saccone G, et al. Hysteroscopic resection vs ultrasound-guided dilation and evacuation for treatment of cesarean scar ectopic pregnancy: a randomized clinical trial. Am J Obstet Gynecol. 2023. PMID: 37142075. doi:10.1016/j.ajog.2023.04.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。